HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kato, H. Articles by Iizuka, T. Search for Related Content PubMed PubMed Citation Articles by Kato, H. Articles by Iizuka, T.

The Annals of Thoracic Surgery, Vol 51, 931-935, Copyright © 1991 by The Society of Thoracic Surgeons

ARTICLES

Evaluation of neck lymph node dissection for thoracic esophageal carcinoma

H Kato, H Watanabe, Y Tachimori and T Iizuka
Department of Surgery, National Cancer Center Hospital, Tokyo, Japan.

We studied a series of 150 patients treated for thoracic esophageal carcinoma at our institution. The patients were divided into two matched groups. Group B underwent transthoracic esophagectomy with mediastinal and abdominal lymphadenectomy only; group A also underwent bilateral neck lymph node dissection. The rates of operative mortality and operative complications did not differ significantly between the two groups. The 5-year survival rate was 38.7% overall (48.7% in group A and 33.7% in group B). Group A had a significantly better survival curve than group B. Twenty patients (26.0%) in group A had metastasis in the dissected neck lymph nodes. The 4-year survival rate of these patients was 47.9%. The significantly better survival of group A and the satisfactory prognosis in the patients with positive cervical lymph nodes demonstrates the effectiveness of neck lymph node dissection in radical operation for thoracic esophageal carcinoma.

This article has been cited by other articles:

				T. Kii, H. Takiuchi, S. Kawabe, M. Gotoh, S. Ohta, T. Tanaka, S. Kuwakado, H. Nishitani, and K.-i. Katsu Evaluation of Prognostic Factors of Esophageal Squamous Cell Carcinoma (Stage II III) After Concurrent Chemoradiotherapy Using Biopsy Specimens Jpn. J. Clin. Oncol., August 20, 2007; (2007) hym077v1. [Abstract] [Full Text] [PDF]

				Y. Ueda, A. Shiozaki, H. Itoi, K. Okamoto, H. Fujiwara, D. Ichikawa, S. Kikuchi, N. Fuji, T. Itoh, T. Ochiai, et al. The Range of Tumor Extension Should Have Precedence over the Location of the Deepest Tumor Center in Determining the Regional Lymph Node Grouping for Widely Extending Esophageal Carcinomas Jpn. J. Clin. Oncol., December 1, 2006; 36(12): 775 - 782. [Abstract] [Full Text] [PDF]

				K. Mimura, K. Kono, M. Hanawa, M. Kanzaki, A. Nakao, A. Ooi, and H. Fujii Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity against Esophageal Squamous Cell Carcinoma Clin. Cancer Res., July 1, 2005; 11(13): 4898 - 4904. [Abstract] [Full Text] [PDF]

				B. Z. Atkins, A. S. Shah, K. A. Hutcheson, J. H. Mangum, T. N. Pappas, D. H. Harpole Jr, and T. A. D'Amico Reducing Hospital Morbidity and Mortality Following Esophagectomy Ann. Thorac. Surg., October 1, 2004; 78(4): 1170 - 1176. [Abstract] [Full Text] [PDF]

				M. Koshy, N. Esiashvilli, J. C. Landry, C. R. Thomas Jr., and R. H. Matthews Multiple Management Modalities in Esophageal Cancer: Epidemiology, Presentation and Progression, Work-up, and Surgical Approaches Oncologist, April 1, 2004; 9(2): 137 - 146. [Abstract] [Full Text] [PDF]

				M. Tachibana, S. Kinugasa, H. Yoshimura, D. K. Dhar, and N. Nagasue Extended Esophagectomy With 3-Field Lymph Node Dissection for Esophageal Cancer Arch Surg, December 1, 2003; 138(12): 1383 - 1389. [Abstract] [Full Text] [PDF]

				W. Fang, H. Kato, Y. Tachimori, H. Igaki, H. Sato, and H. Daiko Analysis of pulmonary complications after three-field lymph node dissection for esophageal cancer Ann. Thorac. Surg., September 1, 2003; 76(3): 903 - 908. [Abstract] [Full Text] [PDF]

				K. Hayashi, N. Ando, H. Watanabe, H. Ide, K. Nagai, N. Aoyama, W. Takiyama, K. Ishida, K. Isono, H. Makuuchi, et al. Phase II Evaluation of Protracted Infusion of Cisplatin and 5-Fluorouracil in Advanced Squamous Cell Carcinoma of the Esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407) Jpn. J. Clin. Oncol., September 1, 2001; 31(9): 419 - 423. [Abstract] [Full Text] [PDF]

				W. Fang, H. Igaki, Y. Tachimori, H. Sato, H. Daiko, and H. Kato Three-field lymph node dissection for esophageal cancer in elderly patients over 70 years of age Ann. Thorac. Surg., September 1, 2001; 72(3): 867 - 871. [Abstract] [Full Text] [PDF]

				H. Igaki, H. Kato, Y. Tachimori, H. Sato, H. Daiko, and Y. Nakanishi Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 887 - 893. [Abstract] [Full Text] [PDF]

				W. Fang, H. Kato, W. Chen, Y. Tachimori, H. Igaki, and H. Sato Comparison of Surgical Management of Thoracic Esophageal Carcinoma Between Two Referral Centers in Japan and China Jpn. J. Clin. Oncol., May 1, 2001; 31(5): 203 - 208. [Abstract] [Full Text] [PDF]

				T. Lerut, W. Coosemans, P. De Leyn, G. Decker, G. Deneffe, and D. Van Raemdonck Is there a role for radical esophagectomy Eur. J. Cardiothorac. Surg., September 1, 1999; 16(suppl_1): S44 - S47. [Abstract] [Full Text] [PDF]

				C. van de Ven, P. De Leyn, W. Coosemans, D. Van Raemdonck, and T. Lerut Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction Eur. J. Cardiothorac. Surg., June 1, 1999; 15(6): 769 - 773. [Abstract] [Full Text] [PDF]

				Y. Tabira, T. Okuma, K. Kondo, and N. Kitamura INDICATIONS FOR THREE-FIELD DISSECTION FOLLOWED BY ESOPHAGECTOMY FOR ADVANCED CARCINOMA OF THE THORACIC ESOPHAGUS J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 239 - 245. [Abstract] [Full Text] [PDF]

				Y. Tachimori, H. Kato, and H. Watanabe SURGERY FOR THORACIC ESOPHAGEAL CARCINOMA WITH CLINICALLY POSITIVE CERVICAL NODES J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 954 - 959. [Abstract] [Full Text] [PDF]

				T. Lerut Esophageal surgery at the end of the millennium J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 1 - 20. [Full Text]

				F. H. Ellis Jr., G. J. Heatley, M. J. Krasna, W. A. Williamson, and K. Balogh ESOPHAGOGASTRECTOMY FOR CARCINOMA OF THE ESOPHAGUS AND CARDIA: A COMPARISON OF FINDINGS AND RESULTS AFTER STANDARD RESECTION IN THREE CONSECUTIVE EIGHT-YEAR INTERVALS WITH IMPROVED STAGING CRITERIA J. Thorac. Cardiovasc. Surg., May 1, 1997; 113(5): 836 - 848. [Abstract] [Full Text]

				T. Matsubara, M. Ueda, O. Yanagida, T. Nakajima, and M. Nishi How extensive should lymph node dissection be for cancer of the thoracic esophagus? J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1073 - 1078. [Abstract] [Full Text]

				D. B. Skinner Invited letter concerning: How extensive should lymph node dissection be for cancer of the thoracic esophagus? J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1154 - 1155. [Full Text]